All Search Results
News Releases
Feb 11, 2026, 09:00 ET Bio-Techne Announces Changes to its Leadership Team
Bio-Techne's next phase of growth." About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 04, 2026, 06:30 ET Bio-Techne Declares Dividend
considered by the Board of Directors on a quarterly basis.Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological
More news about: Bio-Techne Corporation
Feb 04, 2026, 06:30 ET Bio-Techne Releases Second Quarter Fiscal 2026 Results
offset by unfavorable product mix.About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Feb 02, 2026, 06:30 ET Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
about Cultrex Synthetic Hydrogel.About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jan 28, 2026, 06:30 ET Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
www.bio-techne.com/ultrasensitiveAbout Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2
More news about: Bio-Techne Corporation